Biotech China 2014
4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development
Pullman Cologne
Ex Sofitel, Helenenstrasse 14,
KÖLN,, GERMANY 50667
http://
4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery
Informa Life Sciences
http://www.informa-ls.com/imaging
Pullman Cologne
 Ex Sofitel, Helenenstrasse 14,
KÖLN
GERMANY

Schedule of Presentations:

Tuesday, December 2, 2008
07:25:00 CONFERENCE 2 :Optimising Imaging Techniques in Preclinical and Clinical Drug Development
07:25:00 CONFERENCE 1: The Application of Molecular and Cellular Imaging in Drug Discovery
08:00:00 2 : Registration and morning refreshments
08:00:00 1: Registration and morning refreshments
08:00:00 1: check
08:05:00 1: Annoncements
09:00:00 1: Opening remarks from the Chairperson
09:00:00 2 : Opening remarks from the Chairperson Phil Murphy,
09:10:00 1: Illuminating drug discovery with advanced in vivo imaging Keynote Address Vasilis Ntziachristos,
09:10:00 2 : How does imaging help? A thorough analysis of translating preclinical to clinical trials using imaging methods Harsukh , Parmar
09:40:00 2 : A case study of using novel PET tracers in preclinical trials: 35S labelled LNA (locked nucleic acid) olgionucleotides for the development of RNA medicines for oncology and metabolic disorders case study Bo Hansen,
09:40:00 1: Fluorescent proteins and FP-based sensors: Perspectives of use in HCS Vsevolod Belousov,
09:40:00 1: Advances in Probe Development in Drug Discovery and Early Development
09:40:00 2 : Essential developments in preclinical imaging
10:10:00 2 : Optimising the effectiveness of using CT (computed tomography) and NIR (near infrared) imaging in preclinical oncology studies Frauke Alves
10:40:00 1: Advances in multidimensional fluorescence imaging (MDFI) Paul French,
10:40:00 Morning refreshments in the exhibition hall
11:10:00 1: Bioluminescent constructs to obtain a proof-of-concept Clemens W.G.M. Lowik,
11:10:00 2 : Exploring the use of multimodality imaging in preclinical and clinical trials Detlef Stiller,
11:40:00 1: PRACTICAL SESSION: DATA ANALYSIS Getting the most out of automated image analysis Eugenio Fava,
11:40:00 2 : Use of WBA (whole body autoradioluminography) to study tissue distribution of compounds in the early and late stages of preclinical trials Katelijne Anciaux,
11:40:00 1: Applications of High-Content Imaging in Drug Discovery
12:10:00 2 : The limitations and potential of ultra-high resolution (pre-)clinical Single Photon Emission Computed Tomography (SPECT) Freek Beekman,
12:40:00 1: Networking lunch in the exhibition hall
12:40:00 2 : Networking lunch in the exhibition hall
14:00:00 2 : Exploring the value of contrast enhanced functional and molecular ultrasound in oncology research Fabian Kießling,
14:00:00 1: The application of multiparameter imaging Fabio Gasparri
14:30:00 1: Advances in high-content siRNA screening Martin Stöter
14:30:00 2 : The value of optical imaging in preclinical trials: determining the advantages of this technique
15:00:00 2 : MRI (magnetic resonance imaging) of animal models in preclinical research Basil Künnecke,
15:00:00 1: Presentation hosted by BD Biosciences
15:30:00 1: Afternoon refreshments in the exhibition hall
15:30:00 2 : Afternoon refreshments in the exhibition hall
16:00:00 1: Applying small molecular probes to enhance drug discovery imaging
16:00:00 2 : PET for managing the gap between laboratory and man - A Drug Company Perspective Anthony Gee,
16:30:00 2 : Successful implementation of fMRI (functional MRI) and phMRI (pharmacological MRI) in preclinical analgesia studies Jeremy Young,
16:30:00 1: High content screening from acquisition to 3D publication - Opera, Acapella, Columbus and Volocity in concert Claire Stewart,
17:00:00 1: Modelling with 3D high-content cellular imaging in drug discovery Neil Carragher,
17:00:00 2 : An academic perspective: advantages of using MRI (magnetic resonance imaging) to understand pain mechanisms in analgesic drug development Karolina Wartolowska,
17:30:00 1: Using imaging as a means to predict preclinical toxicity L O’Brien
17:30:00 2 : Panel Debate: How translatable is preclinical and clinical imaging? Phil Murphy,, Raymond Josephsson,, Christer Halldin,, Harsukh , Parmar
17:50:00 2 : Closing remarks from the chairperson and end of conference day one Phil Murphy,
18:00:00 1: Closing remarks from the Chairperson and end of conference day one
Wednesday, December 3, 2008
08:25:00 CONFERENCE 1: The Application of Molecular and Cellular Imaging in Drug Discovery
08:25:00 CONFERENCE 2 :Optimising Imaging Techniques in Preclinical and Clinical Drug Development
08:30:00 1: Morning refreshments in the exhibition hall
08:30:00 2 : Morning refreshments in the exhibition hall
08:50:00 2 : Opening remarks from the Chairperson Phil Murphy,
08:50:00 1: Opening remarks from the Chairperson
09:00:00 1: Near-Infrared Spectroscopy
09:00:00 2 : The importance of translatability in imaging and how this can improve preclinical and clinical trials Keynote Address Raymond Josephsson,
09:00:00 1: The application of near-infrared optical imaging in preclinical cancer research Werner Scheuer,
09:40:00 1: New preclinical in vivo models to measure invasion Katarina Wolf,
09:40:00 2 : Vital guidance for imaging in clinical trials
09:40:00 2 : Making the most of clinical trials imaging results: DICOM Data Management Tony O’Sullivan,
09:40:00 1: Utilising Bioluminescence in Optical Imaging
10:10:00 1: Morning refreshments in the exhibition hall
10:10:00 2 : Morning refreshments in the exhibition hall
10:40:00 2 : Spotlight Session
10:40:00 1: Bioluminescence imaging for therapy development in animal models in hemato-oncology and stem-cell based therapy Anton C.M. Martens,
11:10:00 2 : Essential PET updates – what are the novel tracers and what are they being used for? Wolf-Stefan Richter,
11:10:00 1: Positron-Emission Topography (PET) Radiotracers and Applications
11:10:00 1: The synthesis and design of PET radiotracers Anthony Gee,
11:40:00 1: Discussion Forum:Working towards a multimodal approach
11:40:00 2 : Exploiting the benefits of DCE MRI (Dynamic Contrast Enhanced-MRI) in the assessment of antiangiogenic agents Phil Murphy,
12:20:00 1: Networking Lunch in the exhibition hall
12:20:00 2 : Networking lunch in the exhibition hall
13:40:00 2 : What are the new strategies for success in using PET in neuroscience studies? Christer Halldin,
13:40:00 1: Spotlight Session
14:10:00 1: Small animal PET imaging in drug discovery research Detlef Stiller,
14:10:00 2 : Spotlight Session
14:40:00 1: Magnetic Resonance Imaging (MRI)
14:40:00 1: Afternoon networking refreshments in the exhibition hall
14:40:00 2 : Afternoon networking refreshments in the exhibition hall
15:10:00 1: MRI monitoring of inflammatory alterations at the Blood Brain Barrier in Multiple Sclerosis Klaus Petry,
15:10:00 2 : Exploratory imaging in oncology clinical trials - Where are we today? Haren Rupani
15:50:00 1: Applications of New Models and Multimodal Research to Get Results
15:50:00 2 : The use of Positron Emission Tomography to measure drug pharmacokinetics and pharmacodynamics Julian C. Matthews,
15:50:00 1: The use of in vivo models in drug discovery imaging Thomas Krucker,
16:30:00 1: Closing remarks from the Chair and end of conference
16:30:00 2 : Closing remarks from the chairperson and end of conference Phil Murphy,
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.